Zhao JJ - Search Results

1

Unveiling the prognostic significance of malignant ascites in advanced gastrointestinal cancers: a marker of peritoneal carcinomatosis burden.

Provenzano L, Gwee YX, Conca V, Lonardi S, Bozzarelli S, Tamburini E, Passardi A, Zaniboni A, Tosi F, Aprile G, Nasca V, Boccaccino A, Ambrosini M, Vetere G, Carullo M, Guaglio M, Battaglia L, Zhao JJ, Chia DKA, Yong WP, Tan P, So J, Kim G, Shabbir A, Ong CJ, Casella F, Cremolini C, Bencivenga M, Sundar R, Pietrantonio F. Provenzano L, et al. Among authors: zhao jj. Ther Adv Med Oncol. 2024 Nov 4;16:17588359241289517. doi: 10.1177/17588359241289517. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39502404 Free PMC article.

2

Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma: A Meta-analysis Including Low PD-L1 Subgroups.

Yap DWT, Leone AG, Wong NZH, Zhao JJ, Tey JCS, Sundar R, Pietrantonio F. Yap DWT, et al. Among authors: zhao jj. JAMA Oncol. 2023 Feb 1;9(2):215-224. doi: 10.1001/jamaoncol.2022.5816. JAMA Oncol. 2023. PMID: 36480211 Free PMC article.

3

Evidence on Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma-Reply.

Zhao JJ, Pietrantonio F, Sundar R. Zhao JJ, et al. JAMA Oncol. 2023 Jul 1;9(7):1005-1006. doi: 10.1001/jamaoncol.2023.0975. JAMA Oncol. 2023. PMID: 37166787 No abstract available.

4

Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases.

Zhao JJ, Ong CJ, Srivastava S, Chia DKA, Ma H, Huang K, Sheng T, Ramnarayanan K, Ong X, Tay ST, Hagihara T, Tan ALK, Teo MCC, Tan QX, Ng G, Tan JW, Ng MCH, Gwee YX, Walsh R, Law JH, Shabbir A, Kim G, Tay Y, Her Z, Leoncini G, Teh BT, Hong JH, Tay RYK, Teo CB, Dings MPG, Bijlsma M, Lum JHY, Mathur S, Pietrantonio F, Blum SM, van Laarhoven H, Klempner SJ, Yong WP, So JBY, Chen Q, Tan P, Sundar R. Zhao JJ, et al. Gastroenterology. 2024 Dec;167(7):1384-1398.e4. doi: 10.1053/j.gastro.2024.08.007. Epub 2024 Aug 13. Gastroenterology. 2024. PMID: 39147169 Free article.

5

Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience.

Zhao JJ, Kumarakulasinghe NB, Muthu V, Lee M, Walsh R, Low JL, Choo J, Tan HL, Chong WQ, Ang Y, Chan G, Yong WP, Huang Y, Ngoi N, Wong A. Zhao JJ, et al. Oncology. 2021;99(3):192-202. doi: 10.1159/000512000. Epub 2021 Jan 13. Oncology. 2021. PMID: 33440374

6

Low Programmed Death-Ligand 1-Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal Adenocarcinoma.

Zhao JJ, Yap DWT, Chan YH, Tan BKJ, Teo CB, Syn NL, Smyth EC, Soon YY, Sundar R. Zhao JJ, et al. J Clin Oncol. 2022 Feb 1;40(4):392-402. doi: 10.1200/JCO.21.01862. Epub 2021 Dec 3. J Clin Oncol. 2022. PMID: 34860570 Review.

7

First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis.

Fong KY, Zhao JJ, Sultana R, Lee JJX, Lee SY, Chan SL, Yau T, Tai DWM, Sundar R, Too CW. Fong KY, et al. Among authors: zhao jj. Liver Cancer. 2022 Aug 23;12(1):7-18. doi: 10.1159/000526639. eCollection 2023 Feb. Liver Cancer. 2022. PMID: 36872922 Free PMC article.

8

Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer.

Zhao JJ, Fong KY, Chan YH, Tey J, Dawood S, Lee SC, Finn RS, Sundar R, Lim JSJ. Zhao JJ, et al. Cancers (Basel). 2023 Sep 14;15(18):4558. doi: 10.3390/cancers15184558. Cancers (Basel). 2023. PMID: 37760527 Free PMC article.

9

Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants.

Syn NL, Cummings DE, Wang LZ, Lin DJ, Zhao JJ, Loh M, Koh ZJ, Chew CA, Loo YE, Tai BC, Kim G, So JB, Kaplan LM, Dixon JB, Shabbir A. Syn NL, et al. Among authors: zhao jj. Lancet. 2021 May 15;397(10287):1830-1841. doi: 10.1016/S0140-6736(21)00591-2. Epub 2021 May 6. Lancet. 2021. PMID: 33965067

10

KMSubtraction: reconstruction of unreported subgroup survival data utilizing published Kaplan-Meier survival curves.

Zhao JJ, Syn NL, Tan BKJ, Yap DWT, Teo CB, Chan YH, Sundar R. Zhao JJ, et al. BMC Med Res Methodol. 2022 Apr 3;22(1):93. doi: 10.1186/s12874-022-01567-z. BMC Med Res Methodol. 2022. PMID: 35369867 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

999 results

Search Page

Filters